Cannabis Law Report

JULY 7, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. We remain encouraged as we continue our evaluations of MYMD-1 for efficacy and safety – especially as studies continue to suggest we may be able to address many of the concerns that are associated with the current drugs on the market today in these disease areas.”.

Pharmaceutical 81

Pharmaceutical Data Clinical Trials Research and Development 81

Project CBD

NOVEMBER 11, 2023

In general, I think that botanical medicine is safer than pharmaceutical medicine, that the chances of causing harm are much less. So just on safety alone, it’s worth using it. I include pharmaceutical drugs in that category. In general, I think that botanical medicine is safer than pharmaceutical medicine.

Medicine 306

Medicine Research and Development Pharmaceutical Cannabis 306

Veriheal

AUGUST 12, 2021

Unlike “pharmaceutical CBD”—which contains zero traces of the psychoactive compound THC (tetrahydrocannabinol) and has been FDA-approved to treat Dravet syndrome and Lennox-Gastaut syndrome —artisanal CBD is non-mechanized and usually contains variable amounts of CBD and THC. It goes by the name of “artisanal CBD.” .

Epilepsy 81

Epilepsy Pharmaceutical Patients Sleep 81

Project CBD

JULY 28, 2023

with unknown pharmacological and safety profiles.” These hemp hustlers are in it for the money, making active pharmaceutical ingredients using process chemistry and producing formulated end-products like vape pens, gummies, and sodas in garages, airplane hangars, basements, and warehouses. Dr. Mark A.

THC 217

THC Cannabinoids Hemp Research and Development 217

Cannabis Law Report

JUNE 10, 2021

–(BUSINESS WIRE)– CURE Pharmaceutical Holding Corp. We’ve been working to develop safe, accurately-dosed cannabis solutions for several years now and we believe that this collaboration will help us take that initiative to the next level and expand our reach,” said Rob Davidson, CURE Pharmaceutical CEO. OXNARD, Calif.–(BUSINESS

Pharmaceutical 75

Pharmaceutical DEA Research and Development THC 75

NORML

JULY 1, 2019

Previously, Virginia’s five licensed medical cannabis providers, called pharmaceutical processors, would have been limited to dispensing only oils when they open their doors later this year. Virginia Delegate Chris Hurst speaks to HB1720. SCHOOL-USE.

Law 257

Law Patients Access Oil 257

Cannabis Law Report

AUGUST 17, 2021

.–(BUSINESS WIRE)– $MRNS #MarinusPharma — Marinus Pharmaceuticals, Inc. The Phase 2 TSC trial, the CALM trial, was an open-label trial to evaluate the safety and tolerability of adjunctive ganaxolone treatment in patients with seizures associated with TSC. About Marinus Pharmaceuticals. 484-253-6792.

Pharmaceutical 76

Pharmaceutical Clinical Trials Treatment Patients 76

Cannabis Chronicles

APRIL 2, 2019

The Food and Drug Administration says the May 31 meeting will discuss the science, safety and sale of cannabis compounds like CBD. The FDA has approved a pharmaceutical version of CBD to treat rare seizure disorders. It also said any products that make drug or treatment claims also need to be approved by the FDA.

CBD 113

CBD Food Pharmaceutical Collective 113

Cannabis Law Report

JULY 14, 2021

Patients are looking to their medical providers for information on cannabis safety, potential for interactions with pharmaceuticals, and therapeutic applications. cannabis industry is failing to provide consumers and medical patients with much-needed guidance on appropriate use and crucial guarantees of product safety.

Policy 105

Policy Medicine Research and Development Safety 105

Project CBD

MARCH 8, 2019

Immediately in response, the FDA announced that CBD is considered a “drug” and is thus subject to pharmaceutical regulations. In response, veterinarians and others concerned for patient safety promoted a change in state law. Related story.

Pets 218

Pets Legalization Hemp Extraction 218

Cannabis Law Report

JULY 26, 2021

SciSparc intends to evaluate the efficacy, safety and tolerability of its Proprietary Cannabinoid-Based Treatment- SCI-110. SciSparc intends to evaluate the efficacy, safety and tolerability of its SCI-110 in a randomized, double-blind, placebo controlled, cross-over study. About SciSparc (OTCQB: SPRCY): SciSparc Ltd.

Research and Development 105

Research and Development Supply Chain Pharmaceutical Treatment 105

Project CBD

JANUARY 31, 2023

” As per usual, the FDA reflexively privileges pharmaceutical CBD, which is so safe it’s not even considered a controlled substance. A 2018 report by the World Health Organization concluded that CBD “is generally well-tolerated with a good safety profile [and] exhibits no effects indicative of any abuse or dependence potential.”

CBD 130

CBD Clinical Trials Pharmaceutical Food 130

NORML

FEBRUARY 23, 2020

Update : Hb 1343 is scheduled for a Criminal Justice and Public Safety Committee Executive Session at 1pm on 3/3/20 in Legislative Office Building 204. Legislation is pending, House Bill 3960, to repeal the state’s zero tolerance per se traffic safety ban for THC and its metabolites. NH resident? OK resident?

Legislation 252

Legislation Patients Decriminalization Access 252

Cannabis Law Report

SEPTEMBER 24, 2019

Here is the BBC report and below you will find the full press release from GW Pharmaceuticals. The medication, developed by GW Pharmaceuticals, will be used in combination with another epilepsy medication called clobazam. About GW Pharmaceuticals plc and Greenwich Biosciences, Inc. What about other medical cannabis products?

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Cannabis Law Report

OCTOBER 29, 2021

Mydecine Reports Successful Synthesis of Novel Tryptamine Improving the Pharmaceutical Properties of Psilocin. Further strengthens the Company’s drug development pipeline of tryptamines by introducing novel psilocin analogues containing enhancements in safety and efficacy tailored for medical use. October 27, 2021. DENVER, Oct.

Pharmaceutical 52

Pharmaceutical Research and Development Data Safety 52

Project CBD

AUGUST 23, 2023

Earlier this year, the Food & Drug Administration disclosed that it would not regulate non-pharmaceutical CBD products, thereby putting the onus on Congress to devise an appropriate regulatory framework for cannabidiol and other hemp-derived cannabinoids. Caffeine can also be found in pharmaceutical 33 and non-pharmaceutical products.)

Cannabinoids 142

Cannabinoids Hemp THC Safety 142

Cannabis Law Report

AUGUST 27, 2021

The Edmonton, Alberta-based cannabis giant also said that its subsidiary and Ethypharm were selected by the National Agency for the Safety of Medicines and Health Products to supply the entire medical cannabis dried flower range sourced from the company’s EU GMP facility in Denmark Aurora Nordic to French patients as part of the program.

Patients 105

Patients Programs Pharmaceutical Compliance 105

Cannabis Law Report

JUNE 17, 2021

This landmark investment and strategic transaction solidifies Brains’ position as one of the leading pharmaceutical companies in the cannabinoid (CBD) sector. To have the confidence of DSM in this next round solidifies Brains strategic position within the pharmaceutical industry,” said Brains’ CEO & Chairman Rick Brar.

Pharmaceutical 105

Pharmaceutical Clinical Trials Research and Development Events 105

Cannabis Law Report

SEPTEMBER 10, 2021

1 producer of pharmaceutical-grade cannabis nutrients since 1999, creating an intuitive line of products trusted by growers all over the world. The company is committed to the health and safety of all of our teammates in compliance with the most up to date state and federal regulations._*. JUNIOR COUNSEL. West Hollywood, CA.

Compliance 98

Compliance Compliance Safety Policy 98

Cannabis Law Report

JUNE 12, 2021

MONTEREY, CA – Biopharmaceutical Research Company (BRC), an active Drug Enforcement Administration (DEA) license holder, and CURE Pharmaceutical Holding Corp. BRC is a specialty pharmaceutical company that holds several DEA Registrations and is pioneering the federally legal cannabis space in the USA.

DEA 45

DEA Pharmaceutical Research and Development Compliance 45

Cannabis Law Report

AUGUST 5, 2021

Additionally, the technology backed by the patent will be essential for transforming variable psychedelic raw materials into pharmaceutical-grade standardized extracts. This approval represents important progress in the development of our intellectual property,” Benjamin Lightburn, CEO of Filament, said in a press release. “At

Extraction 105

Extraction Clinical Trials Research and Development Pharmaceutical 105

Canna Law Blog

FEBRUARY 21, 2020

Specifically, the FSA is giving the CBD industry until March 31, 2021 to submit valid novel food authorization applications to ensure these products meet specific safety standards. Following the March 31, 2021 deadline, only products for which a valid application has been submitted will be allowed to remain on the market.

Food 116

Food CBD Legalization Hemp 116

Canna Law Blog

JULY 4, 2019

The opening paragraph of the statement is reassuring: Science forms the basis for decisions at the [FDA] and is paramount when it comes to making decisions that will impact the health and safety of the American public. ” The FDA was created to protect the public from unsafe food and drugs.

CBD 98

CBD Hemp Oil Pharmaceutical 98

Cannabis Law Report

JANUARY 18, 2022

.–(BUSINESS WIRE)– #pharma — Virpax ® Pharmaceuticals, Inc. About Virpax Pharmaceuticals. Virpax recently acquired global rights to VRP324, a product candidate for the nasal delivery of a pharmaceutical-grade cannabidiol (CBD) for the management of epilepsy in children (a rare pediatric disease) and adults.

Safety 40

Safety Chronic Pain Research and Development Pharmaceutical 40

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. Enquiries: GW Pharmaceuticals plc.

Pharmaceutical 51

Pharmaceutical Clinical Trials Research and Development Programs 51

Cannabis Law Report

SEPTEMBER 10, 2021

Brazilian pharmaceutical company Prati-Donaduzzi, whose 20 year patent to produce CBD oil was recently revoked, offers an alternative to imported products—even though it is manufactured with imported raw material. Health, in Brazil, is a commodity. Unfortunately. Source: [link].

Policy 103

Policy Oil Concentrates Pharmaceutical 103

Cannabis Law Report

DECEMBER 3, 2021

–(BUSINESS WIRE)– $MRNS #MarinusPharma — Marinus Pharmaceuticals, Inc. Chief Executive Officer of Marinus Pharmaceuticals. “We Chief Executive Officer of Marinus Pharmaceuticals. “We Ganaxolone was generally well-tolerated and no new safety findings emerged in the LGS subgroup. ET (12:00 p.m.

Epilepsy 40

Epilepsy Pharmaceutical Data Clinical Trials 40

Puff Puff Post

FEBRUARY 24, 2020

These results raise safety and efficacy concerns. CBD can be found today in many consumer products from cosmetics and personal care to dietary supplements and pharmaceuticals. “Ensuring accurate CBD dosage labelling is important for consumer safety and efficacy,” said Dr. Guy Setton , CEO of GemmaCert Ltd.

CBD 96

CBD Safety Pharmaceutical Media 96

Veriheal

OCTOBER 29, 2020

Is the focus on the negative impact due to the fact that role players want cannabis to remain illicit as to avoid its potential role in replacing pharmaceutical medication? Those funding research focused on the adverse effects of cannabis consumption are funding the research in order to make concrete conclusions about its safety.

Pharmaceutical 98

Pharmaceutical Therapy Cannabinoids Chronic Pain 98

Cannabis Law Report

JUNE 5, 2021

The Harare government has also approved the establishment of the Green Industry Fund, to promote local beneficiation, skills transfer and development of the local pharmaceutical industry. This is a major departure from the country’s existing foreign investment regime which requires significant local shareholding in any such venture.

Medicine 105

Medicine Pharmaceutical Agriculture Policy 105

Medical Marijuana Program Connection

MAY 1, 2024

CBD brand Pureis®, founded by Loughrea woman Chanelle McCoy, has this week become the frist CBD product to gain a Positive Safety Assessment from the UK’s Food Standards Agency. This endorsement from the FSA Scientific Committee indicates that Pureis® Ultra Pure CBD has successfully fulfilled the rigorous criteria necessary to. Read More

Safety 40

Safety Food CBD Pharmaceutical 40

Canna Law Blog

MARCH 4, 2020

People are increasingly using ketamine for ailments that resist treatment through traditional pharmaceutical drugs. “ Off-label use ” (which is extremely common) is: the use of pharmaceutical drugs for an unapproved indication or in an unapproved age group, dosage, or route of administration.

Therapy 102

Therapy Legalization Chronic Pain DEA 102

MMJ Recs

JUNE 26, 2020

Marijuana Use In Safety Sensitive Job Duties In Oklahoma. Safety Sensitive jobs and work duties were detailed. Employers were given the legal right to take MMJ use into account when their employees would be engaged in Safety Sensitive work. What Are Safety Sensitive Jobs In Oklahoma MMJ Law? Dispensing pharmaceuticals.

Marijuana 69

Marijuana Safety Pharmaceutical Patients 69

Cannabis Law Report

NOVEMBER 16, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, announced today that it has received U.S. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc.

Pharmaceutical 40

Pharmaceutical Clinical Trials Research and Development Therapy 40

Cannabis Law Report

OCTOBER 26, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, announced today that Chris Chapman, M.D., Chapman has operated Chapman Pharmaceutical Consulting, Inc., About MyMD Pharmaceuticals, Inc.

Pharmaceutical 40

Pharmaceutical Clinical Trials Research and Development Therapy 40

Cannabis Law Report

DECEMBER 28, 2021

–(BUSINESS WIRE)– #pharma –Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ:VRPX) achieved significant milestones relating to its pipeline of product candidates as of the end of 2021, which are summarized below. “I About Virpax Pharmaceuticals. BERWYN, Pa.–(BUSINESS

Pharmaceutical 40

Pharmaceutical Research and Development Clinical Trials Chronic Pain 40

Cannabis Law Report

JUNE 2, 2021

and has no accepted medical use in treatment in the United States or lacks accepted safety for use in treatment under medical supervision.” Pharmaceutical Grade CBD Oil. Idaho Code § 37-2701 et seq. A Schedule I substance is one that “has high potential for abuse. Idaho Code § 37-2704. See AG Report at 133.

Law 103

Law Marijuana Oil Pharmaceutical 103